The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money - maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $249.2K by Theodore R. Samuels II, Director at Bristol-Myers Squibb Co. (Symbol: BMY).
Theodore R. Samuels II
Samuels II's average cost works out to $62.30/share. Shares of Bristol-Myers Squibb Co. were changing hands at $65.62 at last check, trading off about 1.8% on Tuesday. The chart below shows the one year performance of BMY shares, versus its 200 day moving average:
Looking at the chart above, BMY's low point in its 52 week range is $51.56 per share, with $70.05 as the 52 week high point - that compares with a last trade of $65.62.
The current annualized dividend paid by Bristol-Myers Squibb Co. is $1.6/share, currently paid in quarterly installments, and its most recent dividend has an upcoming ex-date of 04/05/2018. Below is a long-term dividend history chart for BMY, which can be of good help in judging whether the most recent dividend with approx. 2.4% annualized yield is likely to continue.
According to the ETF Finder at ETF Channel, BMY makes up 7.04% of the iShares U.S. Pharmaceuticals ETF (Symbol: IHE) which is trading lower by about 1.3% on the day Tuesday.